Načítá se...
DARPins: Promising Scaffolds for Theranostics
Monoclonal antibodies are the classical basis for targeted therapy, but the development of alternative binding proteins has made it possible to use non-immunoglobulin proteins as targeting modules. The advantages of DARPins, scaffold proteins based on ankyrin repeats, over antibodies are as follows:...
Uloženo v:
| Vydáno v: | Acta Naturae |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
A.I. Gordeyev
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6977956/ https://ncbi.nlm.nih.gov/pubmed/31993234 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.32607/20758251-2019-11-4-42-53 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|